{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T14:43:26Z","timestamp":1786459406941,"version":"build-2736575974"},"reference-count":47,"publisher":"SAGE Publications","issue":"6","license":[{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Cannabis &amp; Cannabinoid Research"],"published-print":{"date-parts":[[2023,12,1]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>This study examined effects of oral delta-9-tetrahydrocannabinol (THC) in women at two phases of the menstrual cycle differing in circulating levels of estrogen (E). Pre-clinical findings indicate that E increases sensitivity to THC and other cannabinoids, raising the possibility that higher E may be a risk factor for adverse responses to THC in women.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>We examined subjective and behavioral responses to THC (7.5 and 15\u2009mg oral) and placebo in women during the early follicular (EF) phase when E levels are low and the late follicular (LF) phase when E levels are higher. Outcome measures included self-report ratings of drug effects, cardiovascular measures, and biochemical verification of ovarian hormone levels. We hypothesized that women would exhibit greater responses to THC during the LF phase compared to the EF phase.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>On most measures, responses to THC were similar during the two phases. However, on two self-report measures, \u201cWanting More\u201d drug and anxiety, the effects occurred slightly earlier after drug administration in women who were tested during the EF phase.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>We conclude that the differences in levels of E occurring during the early and LF phase of the menstrual cycle do not strongly influence responses to THC. It remains to be determined whether responses are similarly stable across other cycle phases, or in women receiving exogenous hormone treatments.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1089\/can.2022.0045","type":"journal-article","created":{"date-parts":[[2022,5,20]],"date-time":"2022-05-20T11:07:34Z","timestamp":1653044854000},"page":"1117-1125","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":8,"title":["Effects of Oral Delta-9-Tetrahydrocannabinol in Women During the Follicular Phase of the Menstrual Cycle"],"prefix":"10.1177","volume":"8","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6669-7259","authenticated-orcid":false,"given":"Elisa","family":"Pabon","sequence":"first","affiliation":[{"name":"Department of Psychiatry and Behavioral Neuroscience, University of Chicago Medical Center, Chicago, Illinois, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harriet","family":"de Wit","sequence":"additional","affiliation":[{"name":"Department of Psychiatry and Behavioral Neuroscience, University of Chicago Medical Center, Chicago, Illinois, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2023,12,4]]},"reference":[{"key":"e_1_3_6_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2015.02.009"},{"key":"e_1_3_6_3_2","doi-asserted-by":"publisher","DOI":"10.3109\/15563650.2015.1004581"},{"key":"e_1_3_6_4_2","unstructured":"Drug Enforcement Administration. 2020. National Drug Threat Assessment; released: March 2021. Available at: https:\/\/www.dea.gov\/sites\/default\/files\/2021-02\/DIR-008-21%202020%20National%20Drug%20Threat%20Assessment_WEB.pdf (last accessed March30 2022)."},{"key":"e_1_3_6_5_2","doi-asserted-by":"crossref","unstructured":"Carliner H Brown QL Sarvet AL et al. Cannabis use attitudes and legal status in the U.S.: a review. Prev Med. 2017; 104:13\u201323.","DOI":"10.1016\/j.ypmed.2017.07.008"},{"key":"e_1_3_6_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhealeco.2015.03.007"},{"key":"e_1_3_6_7_2","doi-asserted-by":"publisher","DOI":"10.1111\/adb.12968"},{"key":"e_1_3_6_8_2","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-200060060-00005"},{"key":"e_1_3_6_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2013.12.013"},{"key":"e_1_3_6_10_2","doi-asserted-by":"publisher","DOI":"10.3389\/fnbeh.2018.00249"},{"key":"e_1_3_6_11_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11920-014-0511-7"},{"key":"e_1_3_6_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2007.09.004"},{"key":"e_1_3_6_13_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjp.0707465"},{"key":"e_1_3_6_14_2","doi-asserted-by":"publisher","DOI":"10.1037\/pha0000027"},{"key":"e_1_3_6_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbr.2010.07.037"},{"key":"e_1_3_6_16_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1476-5381.2010.00734.x"},{"key":"e_1_3_6_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.psyneuen.2010.02.008"},{"key":"e_1_3_6_18_2","doi-asserted-by":"publisher","DOI":"10.1177\/0269881108089581"},{"key":"e_1_3_6_19_2","doi-asserted-by":"crossref","unstructured":"American Psychiatric Association. Diagnostic and statistical manual of mental disorders 5th ed. American Psychiatric Association: Arlington VA 2013.","DOI":"10.1176\/appi.books.9780890425596"},{"key":"e_1_3_6_20_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1469-8986.2008.00652.x"},{"key":"e_1_3_6_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/0167-8760(90)90050-N"},{"key":"e_1_3_6_22_2","doi-asserted-by":"publisher","DOI":"10.1177\/0269881119862533"},{"key":"e_1_3_6_23_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopsych.2015.12.002"},{"key":"e_1_3_6_24_2","unstructured":"Spielberger CD Gorsuch RL Lushene RE. Manual for the state-trait anxiety inventory. Consulting Psychologists Press: Polo Alto CA 1970."},{"key":"e_1_3_6_25_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1469-8986.1997.tb02140.x"},{"key":"e_1_3_6_26_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00433061"},{"key":"e_1_3_6_27_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-012-2954-z"},{"key":"e_1_3_6_28_2","doi-asserted-by":"publisher","DOI":"10.1002\/cpt1971122part1245"},{"key":"e_1_3_6_29_2","doi-asserted-by":"publisher","DOI":"10.1016\/0376-8716(85)90002-X"},{"key":"e_1_3_6_30_2","unstructured":"McNair DM Lorr M Droppleman LF. Manual for the profile of mood states. Educational and Industrial Testing Services: San Diego CA 1971:27."},{"key":"e_1_3_6_31_2","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0258(20000715)19:13<1793::AID-SIM482>3.0.CO;2-Q"},{"key":"e_1_3_6_32_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11606-019-05235-9"},{"key":"e_1_3_6_33_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-008-1440-0"},{"key":"e_1_3_6_34_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-002-1033-2"},{"key":"e_1_3_6_35_2","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.178.2.101"},{"key":"e_1_3_6_36_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0091-3057(98)00264-0"},{"key":"e_1_3_6_37_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00427443"},{"key":"e_1_3_6_38_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.53.4.703"},{"key":"e_1_3_6_39_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM197208032870501"},{"key":"e_1_3_6_40_2","doi-asserted-by":"publisher","DOI":"10.1002\/cpt1971125762"},{"key":"e_1_3_6_41_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuroimage.2012.07.051"},{"key":"e_1_3_6_42_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.npp.1300496"},{"key":"e_1_3_6_43_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-008-1422-2"},{"key":"e_1_3_6_44_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0091-3057(00)00218-5"},{"key":"e_1_3_6_45_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2005.04.019"},{"key":"e_1_3_6_46_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0187698"},{"key":"e_1_3_6_47_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1043-2760(99)00190-3"},{"key":"e_1_3_6_48_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1098-2396(19991201)34:3<222::AID-SYN6>3.0.CO;2-J"}],"container-title":["Cannabis &amp; Cannabinoid Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1089\/can.2022.0045","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1089\/can.2022.0045","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1089\/can.2022.0045","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T14:11:52Z","timestamp":1777385512000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1089\/can.2022.0045"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,1]]},"references-count":47,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2023,12,1]]}},"alternative-id":["10.1089\/can.2022.0045"],"URL":"https:\/\/doi.org\/10.1089\/can.2022.0045","relation":{},"ISSN":["2578-5125","2378-8763"],"issn-type":[{"value":"2578-5125","type":"print"},{"value":"2378-8763","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,12,1]]}}}